Cellectis (NASDAQ: CLLS) reported Q4 EPS of ($0.16), $0.07 worse than the analyst estimate of ($0.09). Revenue for the quarter came in at $33.22 million versus the consensus estimate of $21.71 million.

For earnings history and earnings-related data on Cellectis (CLLS) click here.